FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称REVUMENIB
异名/同义词2-((4-(7-((TRANS-4-(ETHANESULFONAMIDO)CYCLOHEXYL)METHYL)-2,7-DIAZASPIRO(3.5)NONAN-2-YL)PYRIMIDIN-5-YL)OXY)-N-ETHYL-5-FLUORO-N-(PROPAN-2-YL)BENZAMIDE
BENZAMIDE, N-ETHYL-2-((4-(7-((TRANS-4-((ETHYLSULFONYL)AMINO)CYCLOHEXYL)METHYL)-2,7-DIAZASPIRO(3.5)NON-2-YL)-5-PYRIMIDINYL)OXY)-5-FLUORO-N-(1-METHYLETHYL)-
REVUMENIB
REVUMENIB [INN]
REVUMENIB [USAN]
SNDX50613 FREE BASE
SNDX-50613 FREE BASE
SNDX5613 FREE BASE
SNDX-5613 FREE BASE
CAS登记号2169919-21-3
物质唯一标识(Unique Ingredient Identifier)LZ0M43NNF2
分子式C32H47FN6O4S
国际化合物标识(International Chemical Identifier,InChI)FRVSRBKUQZKTOW-YOCNBXQISA-N
SMILESC1[C@H](CC[C@@H](C1)CN2CCC3(CC2)CN(c4ncncc4Oc5c(C(=O)N(CC)C(C)C)cc(cc5)F)C3)NS(CC)(=O)=O
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System